🇺🇸 FDA

Company profile · Sponsor

AVENUE

AVENUE THERAPEUTICS, INC.

ATXI · NYSE pharma BAY HARBOR ISLANDS, FL, USA
Pipeline
4
Drugs
0
Patents
1

Quick answer

AVENUE (ATXI) is a pharma company. headquartered in BAY HARBOR ISLANDS, FL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker ATXI
Exchange NYSE
Company type pharma
Headquarters BAY HARBOR ISLANDS, FL, USA
SEC CIK 0001644963

Pipeline (4)

Search pipeline →

  1. Artemether-lumefantrine

    AVENUE

    Plasmodium Falciparum Malaria

    phase 3 small molecule completed

    1 trial

  2. Tramadol

    AVENUE

    Pain Management

    phase 3 small molecule active

    3 trials

  3. Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]

    AVENUE

    Acne Vulgaris

    approved small molecule completed

    1 trial

  4. Pyridoxal-5'-Phosphate supplement

    AVENUE

    Neural Inhibition

    small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 6723695

    CTL epitopes from EBV

    Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is AVENUE?

AVENUE (ATXI) is a pharma company. headquartered in BAY HARBOR ISLANDS, FL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does AVENUE sponsor?

We track 4 ClinicalTrials.gov-linked programs for AVENUE, including Artemether-lumefantrine and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does AVENUE company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.